The competition brings together young technologists across the world to help resolve some of the world’s challenges.
The four students, Adeyemo Kayode, Raymond Obinaju, Sobola David and Ahwin Kevin, will be representing Africa at the finals of this year’s edition of the competition in July 2015 at the Microsoft Headquarters in Seattle, United States of America.
According to a statement by the founder of the university, Chief Afe Babalola (SAN), on Sunday, the ABUAD students defeated Team Paradigm, the 2014 Image Cup Winner, to make it to the finals.
The statement said the ABUAD students qualified for the finals after successfully identifying a major health problem and developing a novel technological solution, which they named ‘Asthmavisor,’ a device for the management of asthma, particularly among children.
The statement partly read, “The ABUAD students, otherwise called the Team Lifewatch, presented ‘AsthmaVisor Solution’ a wearable mobile application device which monitors and supervises asthmatic patients’ health status, ensuring that they stay safe and well informed of their environments.
“It is a solution geared towards a more cost-effective and efficient way of supervising asthmatic patients, especially children. AsthmaVisor would be used around the globe in all communities where there are adults and children alike who suffer from this disease.
“The solution will help patients to be more conscious of their environment and will provide a reminder of what their physician has advised them to avoid. The software also provides an automatic alert, which is triggered by change in environmental condition as detected by the sensors in the device. AsthmaVisor further helps the patient acess a selected list of emergency contacts in case he or she is not able to handle an attack.
“Some of the benefits of AsthmaVisor are environmental awareness to situations that could trigger an asthma attack, provision of helpful health tips that could prolong the life of the patients and crucial supervisory and monitoring as well as creating avenue for patients to track their attacks and log crucial information.”
No comments:
Post a Comment
WE LOVE COMMENTS, POST A COMMENT